kennedy disease association kda well hundreds organizations supported passage many living kennedy disease well rare disorders also contacted senators representatives asking support nord issues statement applauding approval ensuring access clinical trials washington september following statement issued peter l saltonstall president ceo national organization rare disorders nord yesterday approval ensuring access clinical trials united states house representatives house representatives echoed senate showed commitment americans families passing ensuring access clinical trials passing house voted remove income related barriers participation clinical trials toward developing much needed treatments known rare diseases hundred currently fda approved treatments today million people families added hope tremendous unmet medical needs one step closer addressed studying one rare disease often lead understanding rare diseases well understanding common diseases ensuring access clinical trials moves president desk close eliminating challenges rare diseases stopping altering ending lives many americans much soon nord proud supported bill advocated passage cystic fibrosis foundation muscular dystrophy association many others rare disease community peter l saltonstall president ceo national organization rare disorders nord read ensuring access clinical trials national organization rare disorders nord established national organization rare disorders nord primary nonprofit organization representing patients families affected rare diseases nord committed identification treatment cure rare diseases affect million americans one every people nord provides programs advocacy education research patient family services improve lives people living rare diseases nord represents disease specific member organizations collaborates many organizations specific causes importance rare disease patient community join nord rarediseases org twitter rarediseases mda also made announcement today regarding passage read announcement link cqrcengage mda advocacy issues eact